Objective

Immunizing pharmacists can administer vaccines; however, they are less likely to administer adolescent vaccines such as vaccines that protect against human papillomavirus (HPV). Although past research has recommended incorporating pharmacists to increase adolescent vaccination, few intervention studies have tested healthcare delivery models that incorporate pharmacists to aid in vaccine series completion. This research explored the feasibility and acceptability of an intervention in which pharmacists administered booster doses of the HPV vaccine series.

Methods

Between April 2019 and February 2020, the research team recruited participants for a pilot randomized controlled trial hosted in one federally qualified health center (FQHC) clinic. Researchers asked intervention group participants to complete the HPV vaccine series with their community pharmacists and control group participants to complete the series at their FQHC. We conducted a pre- and post-intervention surveys and in-depth interviews with both intervention and control group participants.

Results

A total of 33 parents of children who received the first dose of the HPV vaccine enrolled in the study of whom 8 intervention and 11 control group participants completed post-intervention data collection. Although there were no statistically significant changes in vaccine completion and in psychometric variables, we did find that pharmacist-delivered HPV vaccination was acceptable, due, primarily, to convenience. Barriers to receiving pharmacist-administered vaccines included pharmacies’ lack of stocking the vaccine and insurance-related barriers to care.

Conclusion

Although a promising and acceptable healthcare delivery approach, there are still barriers for caregivers to have their children vaccinated against HPV at their community pharmacies.

中文翻译：

---

试验性随机对照试验测试基于药房的 HPV 疫苗完成情况的可行性和可接受性

客观的

免疫药剂师可以管理疫苗；但是，他们不太可能接种青少年疫苗，例如预防人乳头瘤病毒 (HPV) 的疫苗。尽管过去的研究建议结合药剂师来增加青少年疫苗接种，但很少有干预研究测试过结合药剂师来帮助完成疫苗系列的医疗保健提供模式。本研究探讨了药剂师给予 HPV 系列疫苗加强剂量的干预措施的可行性和可接受性。

方法

2019 年 4 月至 2020 年 2 月期间，研究团队招募了参与者，在一家联邦合格健康中心 (FQHC) 诊所开展了一项随机对照试验试点。研究人员要求干预组参与者与他们的社区药剂师一起完成 HPV 疫苗系列，并要求对照组参与者在他们的 FQHC 完成该系列。我们对干预组和对照组的参与者进行了干预前后的调查和深入访谈。

结果

共有 33 名接受了第一剂 HPV 疫苗的孩子的父母参加了研究，其中 8 名干预组参与者和 11 名对照组参与者完成了干预后数据收集。尽管疫苗完成度和心理测量变量在统计学上没有显着变化，但我们确实发现药剂师提供的 HPV 疫苗接种是可以接受的，主要是因为方便。接受药剂师管理的疫苗的障碍包括药店缺乏疫苗库存和与保险相关的护理障碍。

结论

尽管这是一种有前途且可以接受的医疗保健提供方式，但看护人要让他们的孩子在社区药房接种 HPV 疫苗仍然存在障碍。